Last $32.27 USD
Change Today -0.295 / -0.91%
Volume 1.1M
HOLX On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 3:33 PM 03/4/15 All times are local (Market data is delayed by at least 15 minutes).

hologic inc (HOLX) Snapshot

Open
$32.46
Previous Close
$32.57
Day High
$32.50
Day Low
$32.20
52 Week High
03/2/15 - $32.74
52 Week Low
04/25/14 - $20.24
Market Cap
9.0B
Average Volume 10 Days
1.8M
EPS TTM
$0.42
Shares Outstanding
280.0M
EX-Date
--
P/E TM
76.2x
Dividend
--
Dividend Yield
--
Current Stock Chart for HOLOGIC INC (HOLX)

hologic inc (HOLX) Related Businessweek News

No Related Businessweek News Found

hologic inc (HOLX) Details

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States and internationally. The company operates in four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The Diagnostics segment provides Aptima family of assays, target capture/nucleic acid extraction technology, transcription-mediated amplification technology, hybridization protection and dual kinetic assays, instrumentation, Invader chemistry platform, ThinPrep system, fetal fibronectin tests, Procleix family of assays, and virology and infectious disease products. The Breast Health segment provides breast imaging and related products and accessories, including digital and film-based mammography systems; computer-aided detection (CAD) for mammography; invasive breast biopsy devices; breast biopsy site markers; breast biopsy guidance systems; and breast brachytherapy products. This segment also offers Dimensions platform, a mammography gantry for 2D and 3D image acquisition and display; C-View that provides a 2D image; breast MRI coils and workstations; and photoconductor coatings. The GYN Surgical segment provides NovaSure system to treat women suffering from abnormal uterine bleeding; and MyoSure system for the hysteroscopic removal of fibroids. The Skeletal Health segment offers discovery and horizon X-ray bone densitometers that assess the bone density of fracture sites; and mini C-arm imaging systems to perform minimally invasive surgical procedures on a patient’s extremities, such as the hand, wrist, knee, foot, and ankle. Hologic, Inc. sells its products through direct sales and service forces, and a network of independent distributors and sales representatives. The company has a strategic alliance with Quest Diagnostics Incorporated. Hologic, Inc. was founded in 1985 and is headquartered in Bedford, Massachusetts.

5,351 Employees
Last Reported Date: 11/20/14
Founded in 1985

hologic inc (HOLX) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $792.3K
Chief Financial Officer
Total Annual Compensation: $147.1K
Chief Operating Officer
Total Annual Compensation: $199.0K
Executive Officer
Total Annual Compensation: $600.0K
Compensation as of Fiscal Year 2014.

hologic inc (HOLX) Key Developments

Hologic Inc. Presents at Cowen and Company 35th Annual Healthcare Conference, Mar-04-2015 08:00 AM

Hologic Inc. Presents at Cowen and Company 35th Annual Healthcare Conference, Mar-04-2015 08:00 AM. Venue: The Boston Marriott Copley Place, Boston, Massachusetts, United States.

Hologic Inc. Presents at Leerink's Global Healthcare Conference, Feb-11-2015 10:40 AM

Hologic Inc. Presents at Leerink's Global Healthcare Conference, Feb-11-2015 10:40 AM. Venue: Waldorf Astoria New York, New York, New York, United States. Speakers: Robert W. McMahon, Chief Financial Officer.

Hologic Inc. Reports Unaudited Consolidated Earnings Results for the First Quarter Ended December 27, 2014; Provides Earnings Guidance for the Second Quarter of Fiscal 2015; Raises Earnings Guidance for the Full Year 2015

Hologic Inc. reported unaudited consolidated earnings results for the first quarter ended December 27, 2014. For the quarter, the company reported total revenues of $652.8 million compared to $612.5 million a year ago. Income from operations was $103.5 million compared to $61.3 million a year ago. Income before income taxes was $44.1 million compared to loss before income taxes of $1.4 million a year ago. Net income was $29.2 million or $0.10 per basic and diluted share compared to net loss of $5.3 million or $0.02 per basic and diluted share a year ago. Net cash provided by operating activities was $153.5 million compared to $149.3 million a year ago. Purchase of property and equipment was $10.8 million compared to $8.4 million a year ago. Non-GAAP net income was $111.6 million compared to $94.1 million a year ago. Adjusted EBITDA was $233.1 million compared to $213.5 million a year ago. Non-GAAP EPS was $0.39 on a fully diluted basis in the quarter, an increase of 15.4% compared to the prior year period. For the second quarter of fiscal 2015, the company expects revenues of $640 million to $650 million and non-GAAP EPS of $0.38 to $0.39. The company raised earnings guidance for the full year 2015. For the year 2015, the company expects revenues to be $2.57 billion to $2.60 billion from $2.54 billion to $2.57 billion as guided earlier. Non-GAAP EPS expects to be $1.54 to $1.57 from $1.50 to $1.54 as guided earlier.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HOLX:US $32.27 USD -0.295

HOLX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
DENTSPLY International Inc $52.30 USD -0.78
MEDNAX Inc $70.78 USD +0.21
Mettler-Toledo International Inc $312.70 USD -2.49
ResMed Inc $64.77 USD +0.28
Cooper Cos Inc/The $164.10 USD -0.67
View Industry Companies
 

Industry Analysis

HOLX

Industry Average

Valuation HOLX Industry Range
Price/Earnings 100.0x
Price/Sales 3.6x
Price/Book 4.3x
Price/Cash Flow 19.1x
TEV/Sales 1.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HOLOGIC INC, please visit www.hologic.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.